Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Effector Therapeutics Inc (NQ: EFTR )

0.3550 -0.0083 (-2.28%)
Streaming Delayed Price Updated: 11:17 AM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,942
Open 0.3685
Bid (Size) 0.3500 (29)
Ask (Size) 0.3636 (4)
Prev. Close 0.3633
Today's Range 0.3550 - 0.3685
52wk Range 0.3500 - 4.400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences
From eFFECTOR Therapeutics, Inc.
Via Globe NewsWire
Looking Into eFFECTOR Therapeutics's Return On Capital Employed
 
Via Benzinga

Performance

YTD
-20.40%
-20.40%
1 Month
-26.79%
-26.79%
3 Month
-15.48%
-15.48%
6 Month
-37.17%
-37.17%
1 Year
-91.91%
-91.91%

More News

Read More
eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From eFFECTOR Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Wag! Group Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
S&P 500 Down 2%; Mobilicom Shares Spike Higher
Via Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Dow Tumbles More Than 500 Points; US Manufacturing PMI Rises In February
Via Benzinga
eFFECTOR Therapeutics Shares Fall After Data From COVID-19 Treatment Trial
Via Benzinga
eFFECTOR Therapeutics Announces Positive Top-Line Results from Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID
From eFFECTOR Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
eFFECTOR Therapeutics to Present at 2023 BIO CEO & Investor Conference
From eFFECTOR Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
eFFECTOR Therapeutics Shares Jump After Clinical Update Of Investigational Cancer Drug
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
eFFECTOR Therapeutics Provides Positive Clinical Data Update for Zotatifin and General Corporate Update
From eFFECTOR Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.